Glutamatergic Alterations in STZ-Induced Diabetic Rats Are Reversed by Exendin-4. [electronic resource]
- Molecular neurobiology May 2019
- 3538-3551 p. digital
Publication Type: Journal Article
1559-1182
10.1007/s12035-018-1320-5 doi
Animals Astrocytes--drug effects Diabetes Mellitus, Experimental--drug therapy Disease Models, Animal Exenatide--pharmacology Glutamic Acid--metabolism Glycation End Products, Advanced--metabolism Glycosylation Hippocampus--metabolism Male Phosphatidylinositol 3-Kinases--metabolism Pyruvaldehyde--metabolism Rats, Wistar Receptor for Advanced Glycation End Products--metabolism Receptors, N-Methyl-D-Aspartate--metabolism Signal Transduction--drug effects Streptozocin Synaptic Transmission--drug effects